Survey shows 25% of adults consider weight loss drug use without prescription
Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is […]
Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is […]
Treatment with psilocybin appears to offer long-term antidepressant effects which are comparable to those of standard antidepressant therapy with the SSRI drug escitalopram. Subjects taking psilocybin also reported […]
As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that […]
Prescribing rates for stimulants that treat attention-deficit/hyperactivity disorder (ADHD) have increased significantly over the past decade, with some of the largest increases reported during the COVID-19 pandemic. A […]
More than half of the experts on the UK government’s nutrition advisory panel have links to the food industry, reveals an investigation by The BMJ today. At least 11 of […]
Between 2018 and 2020, Australia implemented policy changes to improve the quality and safety of opioid prescribing, with a specific focus on oxycodone. A new study led by […]
New research from the University of Georgia suggests the COVID-19 pandemic may have had an unexpected side effect for postpartum women: more benzodiazepine prescriptions. The new study found that the pandemic […]
Patients who undergo total hip (THA) and total knee replacement surgery (TKA) can successfully reduce opioid doses before surgery with support from a pharmacy-led intervention, according to a […]
A pharmacy professor at Binghamton University, State University of New York has a $1.9 million grant from the National Institute of General Medical Sciences to tackle gene therapy challengs. […]
Patients are “crying out” for help with opioid dose reduction according to evidence gathered during the OpioidHALT study and the impressive results have led to funding of $1.5 […]
Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D). Researchers reported this […]
The results of the OpioidHALT pilot study show that 90% of patients reduced their opioid doses by at least 50% compared with 17% in the control group and […]